September 20, 2017 1:18 PM ET


Company Overview of Editas Medicine, Inc.

Executive Profile

George M. Church Ph.D.

Co-Founder and Scientific Advisory Board Member, Editas Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 27 Board Members in 27 organization across 35 different industries.

See Board Relationships


Dr. George M. Church, Ph.D., serves as a Scientific Advisor of Axcella Health, Inc. (alternative name Pronutria, Inc.). Dr. Church is the Founder and Member of Scientific Advisory Board at AbVitro LLC. He is the Co-Founder of Egenesis Inc. He is the Co-Founder, SAB Chairman and Inventor of READCOOR, INC. Dr. Church co-founded REG Life Sciences, LLC in 2005. He co-founded Editas Medicine Inc. in 2013 and serves its Scientific Advisory Board Member. Dr. Church serves as ...

Corporate Headquarters

11 Hurley Street
Cambridge, Massachusetts 02142

United States

Phone: 617-401-9000
Fax: --

Board Members Memberships

Independent Director


PhD 1994
Harvard University
Post-Doctoral Training
Harvard University
Duke University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Alexander D. Macrae M.B., Ch.B, Ph.D., MRCPCEO, President & Director
Sangamo Therapeutics, Inc.
Rodger Novak M.D.Co-Founder, Chief Executive Officer and Director
CRISPR Therapeutics AG
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Editas Medicine, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at